122 related articles for article (PubMed ID: 7912275)
1. Density of alpha-2A adrenoceptors and Gi proteins in the human brain: ratio of high-affinity agonist sites to antagonist sites and effect of age.
Sastre M; García-Sevilla JA
J Pharmacol Exp Ther; 1994 Jun; 269(3):1062-72. PubMed ID: 7912275
[TBL] [Abstract][Full Text] [Related]
2. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
[TBL] [Abstract][Full Text] [Related]
3. Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry.
Neubig RR; Gantzos RD; Brasier RS
Mol Pharmacol; 1985 Nov; 28(5):475-86. PubMed ID: 2865672
[TBL] [Abstract][Full Text] [Related]
4. Estradiol reduction of the agonist high affinity form of the alpha 2-adrenoceptor in the hypothalamus of female rats: identification as the alpha 2D subtype.
Karkanias GB; Etgen AM
Mol Pharmacol; 1994 Mar; 45(3):509-16. PubMed ID: 7908407
[TBL] [Abstract][Full Text] [Related]
5. Multiple alpha 2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat R alpha-2A adrenergic receptors in cerebral cortex to human H alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes.
Renouard A; Widdowson PS; Millan MJ
J Pharmacol Exp Ther; 1994 Sep; 270(3):946-57. PubMed ID: 7932207
[TBL] [Abstract][Full Text] [Related]
6. Binding of [3H]idazoxan and of its methoxy derivative [3H] RX821002 in human fat cells: [3H]idazoxan but not [3H] RX821002 labels additional non-alpha 2-adrenergic binding sites.
Langin D; Paris H; Lafontan M
Mol Pharmacol; 1990 Jun; 37(6):876-85. PubMed ID: 1972775
[TBL] [Abstract][Full Text] [Related]
7. Does [3H]2-methoxy-idazoxan (RX 821002) detect more alpha-2-adrenoceptor agonist high-affinity sites than [3H]rauwolscine? A comparison of nine tissues and cell lines.
Erdbrügger W; Raulf M; Otto T; Michel MC
J Pharmacol Exp Ther; 1995 Jun; 273(3):1287-94. PubMed ID: 7791100
[TBL] [Abstract][Full Text] [Related]
8. New tools for human fat cell alpha-2A adrenoceptor characterization. Identification on membranes and on intact cells using the new antagonist [3H]RX821002.
Galitzky J; Larrouy D; Berlan M; Lafontan M
J Pharmacol Exp Ther; 1990 Jan; 252(1):312-9. PubMed ID: 1967647
[TBL] [Abstract][Full Text] [Related]
9. Interactions of full and partial agonists with HT29 cell alpha 2-adrenoceptor: comparative study of [3H]UK-14,304 and [3H]clonidine binding.
Paris H; Galitzky J; Senard JM
Mol Pharmacol; 1989 Mar; 35(3):345-54. PubMed ID: 2564632
[TBL] [Abstract][Full Text] [Related]
10. Tight agonist binding may prevent the correct interpretation of agonist competition binding curves for alpha 2-adrenergic receptors.
Convents A; De Backer JP; Convents D; Vauquelin G
Mol Pharmacol; 1987 Jul; 32(1):65-72. PubMed ID: 2885739
[TBL] [Abstract][Full Text] [Related]
11. Human fat cell alpha-2 adrenoceptors. II. Comparative study of partial and full agonist binding parameters using [3H]clonidine and [3H]UK-14,304.
Galitzky J; Lafontan M; Paris H; Berlan M
J Pharmacol Exp Ther; 1989 May; 249(2):592-600. PubMed ID: 2566682
[TBL] [Abstract][Full Text] [Related]
12. Characterization and distribution of alpha 2-adrenergic receptors in the human intestinal mucosa.
Valet P; Senard JM; Devedjian JC; Planat V; Salomon R; Voisin T; Drean G; Couvineau A; Daviaud D; Denis C
J Clin Invest; 1993 May; 91(5):2049-57. PubMed ID: 8098045
[TBL] [Abstract][Full Text] [Related]
13. Characterization of [3H]RX821002 binding to alpha-2 adrenergic receptor subtypes.
O'Rourke MF; Blaxall HS; Iversen LJ; Bylund DB
J Pharmacol Exp Ther; 1994 Mar; 268(3):1362-7. PubMed ID: 7908054
[TBL] [Abstract][Full Text] [Related]
14. Opposite age-dependent changes of alpha 2A-adrenoceptors and nonadrenoceptor [3H]idazoxan binding sites (I2-imidazoline sites) in the human brain: strong correlation of I2 with monoamine oxidase-B sites.
Sastre M; García-Sevilla JA
J Neurochem; 1993 Sep; 61(3):881-9. PubMed ID: 8395564
[TBL] [Abstract][Full Text] [Related]
15. Alpha-2 adrenoceptor in rat jejunum epithelial cells: characterization with [3H]RX821002 and distribution along the villus-crypt axis.
Paris H; Voisin T; Remaury A; Rouyer-Fessard C; Daviaud D; Langin D; Laburthe M
J Pharmacol Exp Ther; 1990 Sep; 254(3):888-93. PubMed ID: 1975626
[TBL] [Abstract][Full Text] [Related]
16. Characterization of binding sites for [3H]-idazoxan, [3H]-P-aminoclonidine and [3H]-rauwolscine in the kidney of the dog.
Evans RG; Haynes JM
Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):649-58. PubMed ID: 7813124
[TBL] [Abstract][Full Text] [Related]
17. Selective increase of alpha2A-adrenoceptor agonist binding sites in brains of depressed suicide victims.
Callado LF; Meana JJ; Grijalba B; Pazos A; Sastre M; García-Sevilla JA
J Neurochem; 1998 Mar; 70(3):1114-23. PubMed ID: 9489732
[TBL] [Abstract][Full Text] [Related]
18. Relationships between beta- and alpha2-adrenoceptors and G coupling proteins in the human brain: effects of age and suicide.
Sastre M; Guimón J; García-Sevilla JA
Brain Res; 2001 Apr; 898(2):242-55. PubMed ID: 11306010
[TBL] [Abstract][Full Text] [Related]
19. Alpha 2-adrenoceptor subtypes identified by [3H]RX821002 binding in the human brain: the agonist guanoxabenz does not discriminate different forms of the predominant alpha 2A subtype.
Sastre M; García-Sevilla JA
J Neurochem; 1994 Sep; 63(3):1077-85. PubMed ID: 7914222
[TBL] [Abstract][Full Text] [Related]
20. Platelet I1-imidazoline binding sites are elevated in depression but not generalized anxiety disorder.
Piletz JE; Halaris A; Nelson J; Qu Y; Bari M
J Psychiatr Res; 1996; 30(3):147-68. PubMed ID: 8884655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
